{
      "brief_title": [
            "comparison",
            "biphasic",
            "insulin",
            "aspart",
            "drug",
            "subject",
            "type",
            "2",
            "diabetes"
      ],
      "brief_summary": [
            "trial",
            "conduct",
            "unite",
            "state",
            "america",
            "usa",
            "purpose",
            "study",
            "test",
            "whether",
            "biphasic",
            "insulin",
            "aspart",
            "safe",
            "least",
            "effective",
            "alternative",
            "combination",
            "two",
            "oral",
            "compare",
            "two",
            "oral",
            "alone",
            "control",
            "blood",
            "glucose"
      ],
      "condition": [
            "mellitus",
            "type",
            "2"
      ],
      "intervention_type": [
            "Drug",
            "Drug",
            "Drug"
      ],
      "intervention_name": [
            "biphasic insulin aspart",
            "pioglitazone",
            "metformin"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "subject",
            "type",
            "2",
            "diabetes",
            "mellitus"
      ],
      "gender": "All",
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "mesh_term": [
            "mellitus",
            "mellitus",
            "type",
            "2",
            "globin",
            "zinc",
            "degludec",
            "insulin",
            "aspart",
            "drug",
            "combination",
            "insulin",
            "aspart"
      ],
      "id": "NCT00097279"
}